本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Trinity Biotech plc

0.7538
+0.00690.92%
成交量:1.54萬
成交額:1.17萬
市值:1,399.53萬
市盈率:-0.33
高:0.7999
開:0.7410
低:0.7301
收:0.7469
資料載入中...
2025/03/26

SEC問詢函

Form CORRESP - Correspondence
2024/11/29

SEC問詢函

Form CORRESP - Correspondence
2024/11/14

超過5%披露

Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
2024/07/12

[修訂]年度報告

Form 20-F/A - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]: [Amend]
2024/06/27

SEC問詢函

Form CORRESP - Correspondence
2024/05/03

SEC問詢函

Form CORRESP - Correspondence
2024/05/01

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/04/30

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/09

超過5%披露

Form SC 13D - General statement of acquisition of beneficial ownership
2024/01/03

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2024/01/02

超過5%披露

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
2023/05/17

年度報告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2023/02/13

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2022/12/08

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2022/09/12

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/25

[修訂]年度報告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/05/23

SEC問詢函

CORRESP [Cover] - Correspondence
2022/05/02

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/02/04

超過5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/04/30

年度報告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]